Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

RPS launches digital ADR checker

The Royal Pharmaceutical Society has launched a new tool which checks for potential adverse drug reactions in patients.

Pharmaceutical Press, the publishing arm of the Royal Pharmaceutical Society (RPS), has launched a digital product allowing clinicians to search for potential adverse drug reactions (ADRs) among more than 1,600 drugs.

Martindale’s ADR Checker, available to MedicinesComplete subscribers, is designed for patient-facing healthcare professionals in their daily practice. Users can search by medicine or medicine class, symptom, or a combination of both. The tool also flags whether an ADR is caused by a single drug, or by concurrent use of multiple drugs. ADRs are listed in order of severity and frequency, and the tool hosts a direct link to the Medicines and Healthcare products Regulatory Agency’s (MHRA’s) Yellow Card Reporting Scheme.

Across Europe, up to 13% of unplanned hospital admissions are caused by ADRs, and in the UK, around 700 patients per year die from avoidable ADRs.

Karen Baxter, managing director of Pharmaceutical Press, said that the ADR Checker “has been designed with the demands of the healthcare environment in mind, and supports the need for quick, evidence-based clinical decision making”.

Paul Bennett, chief executive of the RPS, added: “We recognise the burden of ADRs for both patients and the healthcare system, and the increasing challenges faced by clinicians. The RPS has a key role to play in improving patient outcomes by ensuring the safe and effective use of medicines.”

The ADR Checker has been developed by the team behind the Martindale, British National Formulary and Stockley’s Drug Interactions resources. The data used to create this tool come from multiple sources, including manufacturers’ interactions product information, regulatory advice and published literature.

  • Pharmaceutical Press is owned by the Royal Pharmaceutical Society, the publisher of The Pharmaceutical Journal

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205901

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.